UK | pharmaphorum

UK

News

UK health leaders warn new PM Liz Truss of crisis-in-waiting

New UK Prime Minister Liz Truss needs to take immediate action to prevent the NHS spiralling out of control this winter, according to groups representing healthcare workers.

News

Great Britain £50 - fifty pounds sterling notes spead out.

UK authority asks for director ban for Alliance Pharma CEO

The UK Competition and Markets Authority (CMA) is seeking to disqualify Peter Butterfield, currently chief executive of Alliance Pharma, from serving as a company director.

News

Mereo fights revolt by largest shareholder Rubric

UK biotech Mereo BioPharma is attempting to face down a revolt by Rubric Capital Management – its largest shareholder holding around 14% of the company – which is agitating for changes to i

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

UK advisors back Moderna's bivalent shot for autumn COVID bo...

The UK's Joint Committee on Vaccinations and Immunisations (JCVI) has said that Moderna's bivalent COVID-19 vaccine should be used for the autumn booster campaign in adults.

News

UK first to approve Moderna's Omicron booster jab

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

News

Dismay as UK 'drags its heels' on AZ's COVID antibody Evushe...

Half a million people in the UK with conditions like blood cancer that prevents them being protected from COVID-19 vaccines are facing another winter shielding, because the government has s

UK health leaders warn new PM Liz Truss of crisis-in-waiting

UK authority asks for director ban for Alliance Pharma CEO

Mereo fights revolt by largest shareholder Rubric

UK advisors back Moderna's bivalent shot for autumn COVID bo...

UK first to approve Moderna's Omicron booster jab

Dismay as UK 'drags its heels' on AZ's COVID antibody Evushe...

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

UK

Editor's Picks